5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.39▼ | 7.44▼ | 7.41▼ | 7.49▼ | 7.05▲ |
MA10 | 7.41▼ | 7.42▼ | 7.35▼ | 7.39▼ | 6.76▲ |
MA20 | 7.46▼ | 7.37▼ | 7.46▼ | 6.93▲ | 5.99▲ |
MA50 | 7.39▼ | 7.51▼ | 7.46▼ | 6.74▲ | 7.20▲ |
MA100 | 7.36▼ | 7.45▼ | 7.06▲ | 5.89▲ | 8.58▼ |
MA200 | 7.47▼ | 7.02▲ | 6.85▲ | 6.58▲ | 8.54▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.019▼ | 0.012▲ | -0.009▼ | 0.042▲ | 0.283▲ |
RSI | 40.613▼ | 45.775▼ | 46.652▼ | 56.712▲ | 56.770▲ |
STOCH | 10.002▼ | 60.131 | 58.323 | 75.451 | 72.644 |
WILL %R | -100.000▼ | -68.675 | -46.721 | -32.249 | -22.160▲ |
CCI | -134.247▼ | -20.738 | -28.799 | 46.874 | 125.117▲ |
CDL | $ATXS Doji Candlestick Pattern Detected | Set Alert |
Thursday, September 04, 2025 11:07 PM
Astria Therapeutics, Inc. ( NASDAQ: ATXS) Cantor Global Healthcare Conference 2025 September 4, 2025 3:20 PM EDT ...
|
Wednesday, September 03, 2025 05:13 AM
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present initial ...
|
Wednesday, September 03, 2025 01:59 AM
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at AXIS Capital (NYSE:AXS) and its peers.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 7.30 | 7.625 | 7.245 | 7.34 | 178,670 |
15/09/25 | 7.43 | 7.6455 | 6.99 | 7.37 | 457,861 |
12/09/25 | 7.86 | 7.935 | 7.42 | 7.43 | 291,955 |
11/09/25 | 7.47 | 7.86 | 7.4001 | 7.84 | 337,770 |
10/09/25 | 7.54 | 7.9048 | 7.36 | 7.49 | 460,229 |
09/09/25 | 7.47 | 7.70 | 7.12 | 7.53 | 438,532 |
08/09/25 | 7.56 | 7.61 | 7.22 | 7.43 | 409,567 |
05/09/25 | 7.04 | 7.57 | 6.84 | 7.52 | 543,122 |
04/09/25 | 6.90 | 7.15 | 6.5005 | 7.00 | 406,949 |
03/09/25 | 6.70 | 7.03 | 6.65 | 6.99 | 326,134 |
|
|
||||
|
|
||||
|
|